Product Demo Videos
Dompé is an Italian biopharmaceutical company based in Milan with US headquarters in the San Francisco Bay area. Dompé’s commitment to ophthalmology includes the first topical biologic FDA-approved for an ophthalmic indication.
Allergan, an AbbVie company (NYSE: ABBV), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
OMIC is the largest insurer of ophthalmologists in the United States, and the only insurance carrier dedicated specifically to ophthalmology. OMIC offers competitive rates, premium discounts and dividends.
AdvancedMD offers an integrated suite of cloud solutions including practice management, patient scheduling, billing services, business reporting and analytical reporting, and is uniquely integrated with top Ophthalmology EMR vendors.
Eversight is a nonprofit global eye bank network with a mission to restore sight and prevent blindness through the healing power of eye donation, corneal transplantation and vision research.
MORE THAN A STENT,
A SYSTEM. The Hydrus Microstent from Ivantis, Inc is a revolutionary canal-based minimally invasive glaucoma surgery (MIGS) device for patients with mild to moderate primary open-angled glaucoma.
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
Creating a world connected by Sight. J&J Vision brings together cutting-edge insights, science, technology and people to encourage professionals and patients to proactively preserve and enhance sight for life.
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology.
Glaukos, corporate founder of micro-invasive glaucoma surgery (MIGS), is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma corneal disorders and retinal diseases.
Aerie Pharmaceuticals is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases. Visit us at www.aeriepharma.com
We are IT Professionals across four regional offices that are fully committed to keeping your Practice Technology running so you can provide the best possible care to your patient.
For more than 40 years, we’ve been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.